Skip to main content
VCbacked
Log inGet Started

Linus Biotechnology

New Rochelle, United States

Linus Biotechnology develops a technology platform to improve human health through precision exposome medicine.

$6.1M raised
Aug 2024
Venture - Series Unknown
BiotechnologyHealth CarePharmaceutical

Top Investors

GreatPoint VenturesBow CapitalDivergent InvestmentsSanford RobertsonDavid Bellet Family Office

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Linus Biotechnology

How much funding has Linus Biotechnology raised?
Linus Biotechnology has raised $6.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2024.
Who are Linus Biotechnology's investors?
Linus Biotechnology's investors include GreatPoint Ventures, Bow Capital, Divergent Investments, Sanford Robertson, David Bellet Family Office.
Where is Linus Biotechnology headquartered?
Linus Biotechnology is headquartered in New Rochelle, United States.
What does Linus Biotechnology do?
Linus Biotechnology develops a technology platform to improve human health through precision exposome medicine.
What stage is Linus Biotechnology at?
Linus Biotechnology is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Linus Biotechnology — Funding & Investors." VCBacked, August 12, 2024, https://www.vcbacked.co/company/linus-biotechnology. Accessed July 2, 2026.
APA
VCBacked. (2024). Linus Biotechnology — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/linus-biotechnology
Wikipedia (cite web)
{{cite web |title=Linus Biotechnology — Funding & Investors |url=https://www.vcbacked.co/company/linus-biotechnology |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K